Current use of immunosuppressive agents in inflammatory bowel disease patients in East China

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 24

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

359

HTML

2864

Figures (1-1)

466

Tables (1-1)

424

Sum=4113

Jun 28, 2009 (publication date) through Oct 24, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Gastroenterol. Jun 28, 2009; 15(24): 3055-3059
Published online Jun 28, 2009. doi: 10.3748/wjg.15.3055

Table 1 Clinical characteristics of the study population

	Crohn’s disease	Ulcerative colitis
Number of patients	104	123
Female	42 (40.4%)	56 (45.5%)
Age (yr)	36 (13-70)	45 (15-80)
Disease duration (yr)	4.8 (0.5-24)	5.5 (0.5-23)
Non-smoking	82 (78.8%)	90 (73.2%)
Severity, n (%)
Mild	24 (23.1)	62 (50.4)
Moderate	51 (49)	42 (34.1)
Severe	29 (27.9)	19 (15.5)
Disease distribution, n (%)
Small intestine	44 (42.3)
Ileum and colon	17 (16.3)
Colon	40 (38.5)
Upper digestive tract	3 (2.9)
Disease distribution (UC), n (%)
Distal colon		41 (33.3)
Left side colon		24 (19.5)
Systemic or pan-colon		58 (47.2)
History of any intestinal operation	46 (44.2)	5 (4.1)

Citation: Huang LJ, Zhu Q, Lei M, Cao Q. Current use of immunosuppressive agents in inflammatory bowel disease patients in East China. World J Gastroenterol 2009; 15(24): 3055-3059
URL: https://www.wjgnet.com/1007-9327/full/v15/i24/3055.htm
DOI: https://dx.doi.org/10.3748/wjg.15.3055